Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Bos d 5Canis familiarisHomo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2014SwedenIgE6116.39020140708, Forsberg A
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE2114.70020140331, Rockmann H
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE762.60020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1401.43020130111, Ott H
3.1.4 - Source Sensitized (SPT, IgE)2013PolandIgE21214.10020130424, Kaczmarski M
3.2.1 - Source Sensitized (IgE)2013United StatesIgE3488.24020130409, Kennedy JL
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013PolandIgE7953.60020130424, Kaczmarski M
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE961.04020120528, Patelis A
1.4 - Respiratory Symptoms, Diagnosed2012ItalyIgE7550.13020120821, Liccardi G
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
3.2.1 - Source Sensitized (IgE)2012TaiwanIgE19046.84020121008, Chen FM
5.2.2 - Source Exposed, Adults (Symptoms, SPT)2012FranceIgE10100.00020120910, Bernard H
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE992.02020110223, De Knop KJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012BrazilIgE22100.00020120103, Olivier CE
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012BrazilSPT2268.18020120103, Olivier CE
6.2 - General Population (Adults)2012SwedenIgE3710.27020120528, Patelis A
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1000.00020111214, Zheng YW
5.2.5 - Source Exposed, Children (Symptoms, IgE)2010JapanIgE11597.30020100309, Nakano T
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Austria / Germany / Spain / Italy / FranceIgE7850.00020100923, Hochwallner H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainIgE6779.10020100412, Ibero M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainSPT6779.10020100412, Ibero M
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE200.00020091005, Ott H
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE224.55020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE370.00020090826, Ebo DG
5.7.2 - Source Exposed (Provocation Test - Ingestion)2009PortugalIgE1770.58020090910, Sokolova A
3.1.4 - Source Sensitized (SPT, IgE)2008NetherlandsIgE1346.15020080401, Lam HY
3.1.4 - Source Sensitized (SPT, IgE)2008NetherlandsSPT1118.18020080401, Lam HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008NetherlandsIgE1855.55020080401, Lam HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008NetherlandsSPT1861.11020080401, Lam HY
5.1.1 - Source Exposed (Symptoms)2006ItalyIgE9167.000
5.1.1 - Source Exposed (Symptoms)2006ItalySPT9973.700
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2006SpainIgE23489.00020060407, Martorell A
5.3.1 - Source Exposed (Symptoms, IgE)2005United StatesIgE11336.200
6.3 - General Population (Children)2005EstoniaIgE9610.400
6.3 - General Population (Children)2005ItalyIgE2618.000
6.3 - General Population (Children)2005SwedenIgE1174.300
5.7.2 - Source Exposed (Provocation Test - Ingestion)2004ItalyIgE2070.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2004ItalySPT2195.200
5.7.2 - Source Exposed (Provocation Test - Ingestion)2002ItalyIgE2055.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2002ItalySPT2080.000
5.3.1 - Source Exposed (Symptoms, IgE)1999FranceIgE5877.600
5.3.1 - Source Exposed (Symptoms, IgE)1996ArgentinaIgE8017.500
5.3.1 - Source Exposed (Symptoms, IgE)1996ArgentinaIgE (IB)8012.500
Developed by
Panservice